Literature DB >> 23307184

Migraine-related vertigo and somatoform vertigo frequently occur in children and are often associated.

Thyra Langhagen1, A Sebastian Schroeder, Nicole Rettinger, Ingo Borggraefe, Klaus Jahn.   

Abstract

Migraine-related syndromes are a common cause of episodic vertigo and dizziness in children. Somatoform vertigo (SV) is an important cause of chronic dizziness, especially in adolescents. Our aim was to elucidate the comorbidity of migraine and SV. Three diagnostic groups were defined: migraine-related vertigo (MRV), SV, and combined migraine-related and SV (MSV). A retrospective analysis was performed on patient data (demographics, diagnosis, neuro-orthoptic and neurologic status, and results of vestibular and balance testing) from 168 patients who were presented to the German Center for Vertigo and Balance Disorders (IFB) over a 2.5-year period. Mean age of patients was 12 ± 4 years (range: 1.4 to 18 years). The most frequent diagnosis was MRV (28%), followed by MSV (19%) and SV (14%). MSV occurred most frequently in adolescent girls (25%). MRV was the most common cause of dizziness in our cohort. MSV ranked second overall but ranked first in adolescent girls, followed by isolated SV. SV was most prevalent in adolescent girls. MRV, MSV, and SV account for about 60% of diagnoses established in our tertiary referral center. Competent care of childhood migraine should include skill in detecting both the clinical symptoms of vertigo and overlapping somatoform symptoms. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23307184     DOI: 10.1055/s-0032-1333433

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  13 in total

1.  [Vertigo in children and adolescents. Part 1: Epidemiology and diagnosis of peripheral vestibular disorders].

Authors:  T Langhagen; N Lehnen; E Krause; K Jahn
Journal:  HNO       Date:  2013-09       Impact factor: 1.284

Review 2.  Vestibular Migraine in Children and Adolescents.

Authors:  Thyra Langhagen; Mirjam N Landgraf; Doreen Huppert; Florian Heinen; Klaus Jahn
Journal:  Curr Pain Headache Rep       Date:  2016-12

3.  Dizziness in a Tertiary Care Centre in Sikkim: Our Experience and Limitations.

Authors:  Soumyajit Das; Suvamoy Chakraborty; Sridutt Shekar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-10-09

Review 4.  Considerations for Testing and Treating Children with Central Vestibular Impairments.

Authors:  Jennifer B Christy
Journal:  Semin Hear       Date:  2018-07-20

Review 5.  Epidemiology of Vestibular Impairments in a Pediatric Population.

Authors:  Sylvette R Wiener-Vacher; Juliette Quarez; Audrey Le Priol
Journal:  Semin Hear       Date:  2018-07-20

6.  Vestibular migraine in children and adolescents: clinical findings and laboratory tests.

Authors:  Thyra Langhagen; Nicole Lehrer; Ingo Borggraefe; Florian Heinen; Klaus Jahn
Journal:  Front Neurol       Date:  2015-01-26       Impact factor: 4.003

Review 7.  What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.

Authors:  R Gürkov; I Pyykö; J Zou; E Kentala
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

8.  Vertigo and dizziness in adolescents: Risk factors and their population attributable risk.

Authors:  Filipp M Filippopulos; Lucia Albers; Andreas Straube; Lucia Gerstl; Bernhard Blum; Thyra Langhagen; Klaus Jahn; Florian Heinen; Rüdiger von Kries; Mirjam N Landgraf
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

9.  Unraveling the Etiology of Pediatric Vertigo and Dizziness: A Tertiary Pediatric Center Experience.

Authors:  Nina Božanić Urbančič; Domen Vozel; Jure Urbančič; Saba Battelino
Journal:  Medicina (Kaunas)       Date:  2021-05-11       Impact factor: 2.430

Review 10.  Vertigo in childhood: proposal for a diagnostic algorithm based upon clinical experience.

Authors:  A P Casani; I Dallan; E Navari; S Sellari Franceschini; N Cerchiai
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.